Not sure about your math but yes a .20 PPS multplied by the OS count would be 160m market cap but if you say 20 m in revenue represents the market cap your wrong? Now if you take a 8 times valuation of 20 m revenue you could say that.... Take AMGEN they have a 6 times valuation but the are considered a BP by most, we could see a valuation as high as 13 times when we start to sell LymPro to a broader market or when one of the other products hit the market... I personally believe by years end we will have over half that market 90 m 10 time valuation puts us a little over a dollar, pre split... JMO

Let me be clear of my intentions, I am NOT married to LymPro. I'm here for MANF period!